Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 23

Sort by

Sort Order Select

Journal Articles

Long-Term Outcomes of High-Risk Stage 1/2 Classic Hodgkin Lymphoma Managed with an Advanced Stage Treatment Approach

Jowon Laura Kim, Diego Villa, R. Petter Tonseth, Alina S. Gerrie, Don Wilson, Francois Benard, Christopher P. Venner, Brian Skinnider, Pedro Farinha, Graham W. Slack, Randy D. Gascoyne, David W. Scott, Joseph M. Connors, Laurie H. Sehn, Kerry J. Savage

Blood (2022) 140 (Supplement 1): 9437–9438.

https://doi.org/10.1182/blood-2022-162199

Published: 2022

Journal Articles

Long-Term Outcomes of Patients Aged 65 Years or Older with Peripheral T-Cell Lymphoma, Not Otherwise Specified (PTCL-NOS) and T-Follicular Helper T-Cell Lymphoma (TFHTCL) Treated with Curative Intent CHOP(like) Chemotherapy

Henry S. Ngu, Diego Villa, Alina S. Gerrie, Christopher P. Venner, Andrew Lytle, Brian Skinnider, Jeffrey W. Craig, Graham W. Slack, David W. Scott, Laurie H. Sehn, Kerry J. Savage

Blood (2022) 140 (Supplement 1): 3713–3715.

https://doi.org/10.1182/blood-2022-168586

Published: 2022

Journal Articles

Frontline Therapy with Bendamustine-Rituximab (BR) in Patients with Treatment-Naïve Waldenstrom's Macroglobulinemia Confers Similar Long-Term Outcomes to R-CVP in a Real-World Setting: A Population-Based Analysis

Jowon Laura Kim, Alina S. Gerrie, Kerry J. Savage, Diego Villa, David W. Scott, Jeffrey W Craig, Pedro Farinha, Brian Skinnider, Graham W. Slack, Joseph M. Connors, Laurie H. Sehn, Ciara L. Freeman

Blood (2021) 138 (Supplement 1): 1353.

https://doi.org/10.1182/blood-2021-146738

Published: 2021

Journal Articles

Long-term results of PET-guided radiation in patients with advanced-stage diffuse large B-cell lymphoma treated with R-CHOP

Ciara L. Freeman, Kerry J. Savage, Diego R. Villa, David W. Scott, Line Srour, Alina S. Gerrie, Maura J. Brown, Graham W. Slack, Pedro Farinha, Brian Skinnider, James Morris, François Bénard, Christina Aquino-Parsons, Andrea Lo, Tom Pickles, Don C. Wilson, Petter Tonseth, Joseph M. Connors, Laurie H. Sehn

Blood (2021) 137 (7): 929–938.

https://doi.org/10.1182/blood.2020005846

Published: 2021

Includes: Supplemental data

Journal Articles

Outcome of primary mediastinal large B-cell lymphoma using R-CHOP: impact of a PET-adapted approach

Anna R. Hayden, Petter Tonseth, Derrick G. Lee, Diego Villa, Alina S. Gerrie, David W. Scott, Ciara L. Freeman, Graham W. Slack, Pedro Farinha, Brian Skinnider, Paul R. Yenson, Francois Benard, Andrea Lo, Tom Pickles, Donald Wilson, Joseph M. Connors, Laurie H. Sehn, Kerry J. Savage

Blood (2020) 136 (24): 2803–2811.

https://doi.org/10.1182/blood.2019004296

Published: 2020

Includes: Supplemental data

Journal Articles

Outcome of Limited Stage Nodular Lymphocyte Predominant Hodgkin Lymphoma (NLPHL) and Evaluation of a PET-Adapted Approach

Phoebe Tsz Man Cheng, BSc,MD, Diego Villa, MD MPH, R. Petter Tonseth, MD, David W. Scott, MBChB, PhD, Alina S Gerrie, MD MPH, Ciara L Freeman, MSc, MBBChir, Christina Aquino Parsons, MD, Tom Pickles, MD, Andrea Lo, MD, Don Wilson, MD, Brian Skinnider, MD, Laurie H Sehn, MD, Joseph M Connors, MD, Kerry J Savage, BSc, MD MSc

Blood (2019) 134 (Supplement_1): 2845.

https://doi.org/10.1182/blood-2019-122019

Published: 2019

Journal Articles

Molecular Correlates of Central Nervous System Relapse in Diffuse Large B-Cell Lymphoma

Robert Kridel, MDMPH,PhD, Keren Isaev, MSc, Daisuke Ennishi, MD PhD, Brian Skinnider, MD, Karen Mungall, PhD, Andrew J. Mungall, PhD, Mehran Bakhtiari, MSc, Rosemarie Tremblay-Lemay, MD MSc, FRCPC, Barbara Meissner, PhD, Susana Ben-Neriah, BSc, Merrill Boyle, BSc, Diego Villa, MD MPH, Marco A. Marra, PhD, Christian Steidl, MD, Randy D. Gascoyne, MD, Kerry J Savage, BSc, MD MSc, David W. Scott, MBChB, PhD

Blood (2019) 134 (Supplement_1): 2763.

https://doi.org/10.1182/blood-2019-124235

Published: 2019

Journal Articles

Early progression after bendamustine-rituximab is associated with high risk of transformation in advanced stage follicular lymphoma

Ciara L. Freeman, Robert Kridel, Alden A. Moccia, Kerry J. Savage, Diego R. Villa, David W. Scott, Alina S. Gerrie, David Ferguson, Fergus Cafferty, Graham W. Slack, Pedro Farinha, Brian Skinnider, Joseph M. Connors, Laurie H. Sehn

Blood (2019) 134 (9): 761–764.

https://doi.org/10.1182/blood.2019000258

Published: 2019

Includes: Supplemental data

Journal Articles

Frontline Therapy with Bendamustine and Rituximab (BR) in Follicular Lymphoma: Prognosis Among Patients with Progression of Disease By 24 Months (POD24) Is Poor with Majority Having Transformed Lymphoma

Ciara Louise Freeman, MRCP, MSc, FRCPath, MBBChir, Kerry J Savage, BSc, MD MSc, Diego Villa, MD, David W. Scott, PhDMD, FRACP, FRCPA, Alina S. Gerrie, MD MPH, David J Ferguson, Fergus Cafferty, Graham W Slack, MD, Pedro Farinha, MD PhD, Brian Skinnider, Joseph M. Connors, MD, Laurie H Sehn, MD MPH

Blood (2018) 132 (Supplement 1): 2873.

https://doi.org/10.1182/blood-2018-99-113675

Published: 2018

Journal Articles

Long-Term Results of PET-Guided Radiation Therapy in Patients with Advanced-Stage Diffuse Large B-Cell Lymphoma Treated with R-CHOP in British Columbia

Ciara Louise Freeman, MRCP, MD, Kerry J Savage, BSc, MD MSc, Diego Villa, MD, David W. Scott, MD PhD FRACP, FRCPA, Line Srour, MD, Alina S Gerrie, MD, Maura J Brown, Graham W Slack, MD, Pedro Farinha, Brian Skinnider, Christina Aquino Parsons, Tom Pickles, MD FRCPC, Pete Tonseth, Don Wilson, Joseph M Connors, MD, Laurie H. Sehn, MDMPH

Blood (2017) 130 (Supplement 1): 823.

https://doi.org/10.1182/blood.V130.Suppl_1.823.823

Published: 2017

Journal Articles

Advanced-stage nodular lymphocyte predominant Hodgkin lymphoma compared with classical Hodgkin lymphoma: a matched pair outcome analysis

Katharine H. Xing, Joseph M. Connors, Anky Lai, Mubarak Al-Mansour, Laurie H. Sehn, Diego Villa, Richard Klasa, Tamara Shenkier, Randy D. Gascoyne, Brian Skinnider, Kerry J. Savage

Blood (2014) 123 (23): 3567–3573.

https://doi.org/10.1182/blood-2013-12-541078

Published: 2014

Journal Articles

Herpes simplex virus lymphadenitis

Diego Villa, Brian Skinnider

Blood (2014) 123 (1): 12.

https://doi.org/10.1182/blood-2013-09-524272

Published: 2014

Journal Articles

Outcomes In Splenic Marginal Zone Lymphoma: Analysis Of 108 Patients Treated In British Columbia (BC)

Katharine He Xing, MD, Amrit Kahlon, MD, Joseph M. Connors, MD, Brian Skinnider, MD, Randy D. Gascoyne, MD, Laurie H. Sehn, MD, MPH, Kerry J. Savage, MD, MSc, Graham W. Slack, MD, Tamara Shenkier, MD, Richard Klasa, MD, Alina S. Gerrie, MD, Diego Villa, MD, MPH

Blood (2013) 122 (21): 4369.

https://doi.org/10.1182/blood.V122.21.4369.4369

Published: 2013

Journal Articles

Impact of Time from Diagnosis to Initiation of Curative-Intent Chemotherapy on Clinical Outcomes in Patients with Hodgkin Lymphoma

Edward G. Brooks, MD, Joseph M. Connors, MD, Laurie H. Sehn, MD, Randy D. Gascoyne, MD, Kerry J. Savage, MD, MSc, Tamara Shenkier, MD, Richard Klasa, MD, Alina S. Gerrie, MD, Brian Skinnider, MD, Graham Slack, MD, Diego Villa, MD, MPH

Blood (2013) 122 (21): 4237.

https://doi.org/10.1182/blood.V122.21.4237.4237

Published: 2013

Journal Articles

The Outcome of Advanced Stage Nodular Lymphocyte Predominant Hodgkin's Lymphoma (NLPHL) Compared to Classical Hodgkin's Lymphoma (CHL): A Matched Pair Analysis

Katharine He Xing, MD, Joseph M. Connors, MD, Mubarak Al-Mansour, MD, Randy D. Gascoyne, MD, Brian Skinnider, MD, Kerry J. Savage, MD MSc

Blood (2012) 120 (21): 1531.

https://doi.org/10.1182/blood.V120.21.1531.1531

Published: 2012

Journal Articles

Treating limited-stage nodular lymphocyte predominant Hodgkin lymphoma similarly to classical Hodgkin lymphoma with ABVD may improve outcome

Kerry J. Savage, Brian Skinnider, Mubarak Al-Mansour, Laurie H. Sehn, Randy D. Gascoyne, Joseph M. Connors

Blood (2011) 118 (17): 4585–4590.

https://doi.org/10.1182/blood-2011-07-365932

Published: 2011

Journal Articles

Incorporation of ABVD Increases Cure Rates of Patients with Limited Stage Nodular Lymphocyte Predominant Hodgkin Lymphoma (NLPHL)

Kerry Joanne Savage, MD, MSc, Brian Skinnider, MD, Mubarak Al Mansour, MD, Laurie H Sehn, MD, MPH, Randy D. Gascoyne, MD, Joseph M. Connors, MD

Blood (2010) 116 (21): 3887.

https://doi.org/10.1182/blood.V116.21.3887.3887

Published: 2010

Journal Articles

Gemcitabine, Dexamethasone, and Cisplatin (GDP) Is An Effective and Well-Tolerated out-Patient Salvage Therapy for Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) and Hodgkin Lymphoma (HL)

Alden A. Moccia, Felicitas Hitz, Paul Hoskins, Richard Klasa, Maryse Power, Kerry J. Savage, Tamara Shenkier, John Shepherd, Brian Skinnider, Graham W. Slack, Kevin Song, Randy D. Gascoyne, Joseph M. Connors, Laurie Sehn

Blood (2010) 116 (21): 113.

https://doi.org/10.1182/blood.V116.21.113.113

Published: 2010

Journal Articles

The International Prognostic Factor Project Score (IPS) in Advanced Stage Hodgkin Lymphoma Has Limited Utility in Patients Treated in the Modern Era.

Moccia A. Moccia, Jane Donaldson, Mukesh Chhanabhai, Paul Hoskins, Richard Klasa, Kerry J. Savage, Tamara Shenkier, Brian Skinnider, Randy D. Gascoyne, Joseph M. Connors, Laurie H. Sehn

Blood (2009) 114 (22): 1554.

https://doi.org/10.1182/blood.V114.22.1554.1554

Published: 2009

Journal Articles

Follicular Non-Hodgkin Lymphoma Grade 3a and 3b Subtypes Exhibit Similar Clinical Behaviour and Treatment Outcome

Jesse Shustik, MD, Michael Quinn, MD, Joseph M Connors, MD, Randy D Gascoyne, MD, Brian Skinnider, MD, Laurie H Sehn, MD, MPH

Blood (2008) 112 (11): 3777.

https://doi.org/10.1182/blood.V112.11.3777.3777

Published: 2008

NARROW

Long-Term Outcomes of High-Risk Stage 1/2 Classic Hodgkin Lymphoma Managed with an Advanced Stage Treatment Approach

Long-Term Outcomes of Patients Aged 65 Years or Older with Peripheral T-Cell Lymphoma, Not Otherwise Specified (PTCL-NOS) and T-Follicular Helper T-Cell Lymphoma (TFHTCL) Treated with Curative Intent CHOP(like) Chemotherapy

Frontline Therapy with Bendamustine-Rituximab (BR) in Patients with Treatment-Naïve Waldenstrom's Macroglobulinemia Confers Similar Long-Term Outcomes to R-CVP in a Real-World Setting: A Population-Based Analysis

Long-term results of PET-guided radiation in patients with advanced-stage diffuse large B-cell lymphoma treated with R-CHOP

Outcome of primary mediastinal large B-cell lymphoma using R-CHOP: impact of a PET-adapted approach

Outcome of Limited Stage Nodular Lymphocyte Predominant Hodgkin Lymphoma (NLPHL) and Evaluation of a PET-Adapted Approach

Molecular Correlates of Central Nervous System Relapse in Diffuse Large B-Cell Lymphoma

Early progression after bendamustine-rituximab is associated with high risk of transformation in advanced stage follicular lymphoma

Frontline Therapy with Bendamustine and Rituximab (BR) in Follicular Lymphoma: Prognosis Among Patients with Progression of Disease By 24 Months (POD24) Is Poor with Majority Having Transformed Lymphoma

Long-Term Results of PET-Guided Radiation Therapy in Patients with Advanced-Stage Diffuse Large B-Cell Lymphoma Treated with R-CHOP in British Columbia

Advanced-stage nodular lymphocyte predominant Hodgkin lymphoma compared with classical Hodgkin lymphoma: a matched pair outcome analysis

Herpes simplex virus lymphadenitis

Outcomes In Splenic Marginal Zone Lymphoma: Analysis Of 108 Patients Treated In British Columbia (BC)

Impact of Time from Diagnosis to Initiation of Curative-Intent Chemotherapy on Clinical Outcomes in Patients with Hodgkin Lymphoma

The Outcome of Advanced Stage Nodular Lymphocyte Predominant Hodgkin's Lymphoma (NLPHL) Compared to Classical Hodgkin's Lymphoma (CHL): A Matched Pair Analysis

Treating limited-stage nodular lymphocyte predominant Hodgkin lymphoma similarly to classical Hodgkin lymphoma with ABVD may improve outcome

Incorporation of ABVD Increases Cure Rates of Patients with Limited Stage Nodular Lymphocyte Predominant Hodgkin Lymphoma (NLPHL)

Gemcitabine, Dexamethasone, and Cisplatin (GDP) Is An Effective and Well-Tolerated out-Patient Salvage Therapy for Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) and Hodgkin Lymphoma (HL)

The International Prognostic Factor Project Score (IPS) in Advanced Stage Hodgkin Lymphoma Has Limited Utility in Patients Treated in the Modern Era.

Follicular Non-Hodgkin Lymphoma Grade 3a and 3b Subtypes Exhibit Similar Clinical Behaviour and Treatment Outcome

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only